In vitro extracorporeal shock wave treatment enhances stemness and preserves multipotency of rat and human adipose-derived stem cells

Cytotherapy

Volumn 16, Issue 12, 2014, Pages 1666-1678

  Schuh, Christina Maria Anna Pia ^a,b,c   Heher, Philipp ^a,b   Weihs, Anna Maria ^b,c   Banerjee, Asmita ^a,b   Fuchs, Christiane ^b,c   Gabriel, Christian ^d   Wolbank, Susanne ^a,b   Mittermayr, Rainer ^a,b   Redl, Heinz ^a,b   Rünzler, Dominik ^b,c   Teuschl, Andreas Herbert ^b,c  

^a LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^b AUSTRIAN CLUSTER FOR TISSUE REGENERATION   (Austria)

^c UNIVERSITY OF APPLIED SCIENCES TECHNIKUM WIEN   (Austria)

^d Red Cross Blood Transfusion Service of Upper Austria   (Austria)

Author keywords

Adipose derived stem cells; Extracorporeal shock wave treatment; Multipotency; Schwann like cells; Stemness

Indexed keywords

5' NUCLEOTIDASE; BIGLYCAN; ENDOGLIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; OSTEOCALCIN; THY 1 ANTIGEN; DIFFERENTIATION ANTIGEN;

ADIPOSE DERIVED STEM CELL; ADULT; ANIMAL CELL; ARTICLE; BIGLYCAN GENE; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; EXTRACORPOREAL LITHOTRIPSY; FEMALE; FLOW CYTOMETRY; GAPDH GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MARKER GENE; MULTIPOTENT STEM CELL; NONHUMAN; OSTEOCALCIN GENE; PHENOTYPE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHWANN CELL; ANIMAL; BIOLOGICAL THERAPY; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; GENE EXPRESSION REGULATION; METABOLISM; PROCEDURES; RADIATION; SPRAGUE DAWLEY RAT;

RATTUS;

ADULT; ANIMALS; ANTIGENS, DIFFERENTIATION; CELL- AND TISSUE-BASED THERAPY; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; HIGH-ENERGY SHOCK WAVES; HUMANS; MALE; MULTIPOTENT STEM CELLS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84911905213     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2014.07.005     Document Type: Article

References (58)

1. Javazon E.H., Beggs K.J., Flake A.W. Mesenchymal stem cells: paradoxes of passaging. Exp Hematol 2004, 32:414-425.
2. Bianco P., Riminucci M., Gronthos S., Robey P.G. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001, 19:180-192.
3. Lee O.K., Kuo T.K., Chen W.-M., Lee K.-D., Hsieh S.-L., Chen T.-H. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004, 103:1669-1675.
4. Kern S., Eichler H., Stoeve J., Klüter H., Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006, 24:1294-1301.
5. Fan H., Liu H., Toh S.L., Goh J.C.H. Enhanced differentiation of mesenchymal stem cells co-cultured with ligament fibroblasts on gelatin/silk fibroin hybrid scaffold. Biomaterials 2008, 29:1017-1027.
6. Väänänen H.K. Mesenchymal stem cells. Ann Med 2005, 37:469-479.
7. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
8. Strem B.M., Hicok K.C., Zhu M., Wulur I., Alfonso Z., Schreiber R.E., et al. Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med 2005, 54:132-141.
9. Dezawa M., Takahashi I., Esaki M., Takano M., Sawada H. Sciatic nerve regeneration in rats induced by transplantation of in vitro differentiated bone-marrow stromal cells. Eur J Neurosci 2001, 14:1771-1776.
10. Jiang L., Zhu J.-K., Liu X.-L., Xiang P., Hu J., Yu W.-H. Differentiation of rat adipose tissue-derived stem cells into Schwann-like cells in vitro. NeuroReport 2008, 19:1015-1019.
11. Barry F.P., Murphy J.M. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 2004, 36:568-584.
12. Chamberlain G., Fox J., Ashton B., Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007, 25:2739-2749.
13. Kronsteiner B., Wolbank S., Peterbauer A., Hackl C., Redl H., van Griensven M., et al. Human mesenchymal stem cells from adipose tissue and amnion influence T-cells depending on stimulation method and presence of other immune cells. Stem Cells Dev 2011, 20:2115-2126.
14. Nasef A., Mathieu N., Chapel A., Frick J., Francois S., Mazurier C., et al. Immunosuppressive effects of mesenchymal stem cells: Involvement of HLA-G. Transplantation 2007, 84:231-237.
15. Siddappa R., Licht R., van Blitterswijk C., de Boer J. Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. JOrthop Res 2007, 25:1029-1041.
16. Kretlow J.D., Jin Y.-Q., Liu W., Zhang W.J., Hong T.-H., Zhou G., et al. Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells. BMC Cell Biol 2008, 9:60.
17. Bonab M.M., Alimoghaddam K., Talebian F., Ghaffari S.H., Ghavamzadeh A., Nikbin B. Aging of mesenchymal stem cell in vitro. BMC Cell Biol 2006, 7:14.
18. Ross S.E., Hemati N., Longo K.A., Bennett C.N., Lucas P.C., Erickson R.L., et al. Inhibition of adipogenesis by Wnt signaling. Science 2000, 289:950-953.
19. Bourin P., Bunnell B.A., Casteilla L., Dominici M., Katz A.J., March K.L., et al. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International So. Cytotherapy 2013, 15:641-648.
20. Maioli M., Rinaldi S., Santaniello S., Castagna A., Pigliaru G., Delitala A., et al. Radio electric asymmetric conveyed fields and human adipose-derived stem cells obtained with a non-enzymatic method and device: a novel approach to multipotency. Cell Transplant 2013.
21. Kang K.S., Hong J.M., Kang J.A., Rhie J.-W., Cho D.-W. Osteogenic differentiation of human adipose-derived stem cells can be accelerated by controlling the frequency of continuous ultrasound. JUltrasound Med 2013, 32:1461-1470.
22. Raabe O., Shell K., Goessl A., Crispens C., Delhasse Y., Eva A., et al. Effect of extracorporeal shock wave on proliferation and differentiation of equine adipose tissue-derived mesenchymal stem cells in vitro. Am J Stem Cells 2013, 2:62-73.
23. Kaude J.V., Williams C.M., Millner M.R., Scott K.N., Finlayson B. Renal morphology and function immediately after extracorporeal shock-wave lithotripsy. AJR Am J Roentgenol 1985, 145:305-313.
24. Schaden W., Fischer A., Sailler A. Extracorporeal shock wave therapy of nonunion or delayed osseous union. Clin Orthop Relat Res 2001, 90-94.
25. Furia J.P., Juliano P.J., Wade A.M., Schaden W., Mittermayr R. Shock wave therapy compared with intramedullary screw fixation for nonunion of proximal fifth metatarsal metaphyseal-diaphyseal fractures. JBone Joint Surg Am Vol 2010, 92:846-854.
26. Elster E.A., Stojadinovic A., Forsberg J., Shawen S., Andersen R.C., Schaden W. Extracorporeal shock wave therapy for nonunion of the tibia. JOrthop Trauma 2010, 24:133-141.
27. Mittermayr R., Hartinger J., Antonic V., Meinl A., Pfeifer S., Stojadinovic A., et al. Extracorporeal shock wave therapy (ESWT) minimizes ischemic tissue necrosis irrespective of application time and promotes tissue revascularization by stimulating angiogenesis. Ann Surg 2011, 253:1024-1032.
28. Hausner T., Pajer K., Halat G., Hopf R., Schmidhammer R., Redl H., et al. Improved rate of peripheral nerve regeneration induced by extracorporeal shock wave treatment in the rat. Exp Neurol 2012, 236:363-370.
29. Schaden W., Thiele R., Kölpl C., Pusch M., Nissan A., Attinger C.E., et al. Shock wave therapy for acute and chronic soft tissue wounds: a feasibility study. JSurg Res 2007, 143:1-12.
30. Saggini R., Figus A., Troccola A., Cocco V., Saggini A., Scuderi N. Extracorporeal shock wave therapy for management of chronic ulcers in the lower extremities. Ultrasound Med Biol 2008, 34:1261-1271.
31. Haupt G. Use of extracorporeal shock waves in the treatment of pseudarthrosis, tendinopathy and other orthopedic diseases. JUrol 1997, 158:4-11.
32. Davis T.A., Stojadinovic A., Anam K., Amare M., Naik S., Peoples G.E., et al. Extracorporeal shock wave therapy suppresses the early proinflammatory immune response to a severe cutaneous burn injury. Int Wound J 2009, 6:11-21.
33. Rompe J.D., Hope C., Küllmer K., Heine J., Bürger R. Analgesic effect of extracorporeal shock-wave therapy on chronic tennis elbow. JBone Joint Surg Br Vol 1996, 78:233-237.
34. Ogden J.A., Tóth-Kischkat A., Schultheiss R. Principles of shock wave therapy. Clin Orthop Relat Res 2001, 8-17.
35. Chen Y.J., Wurtz T., Wang C.J., Kuo Y.R., Yang K.D., Huang H.C., et al. Recruitment of mesenchymal stem cells and expression of TGF-β1 and VEGF in the early stage of shock wave-promotedbone regeneration of segmental defect in rats. JOrthop Res 2004, 22:526-534.
36. Wolbank S., Peterbauer A., Fahrner M., Hennerbichler S., van Griensven M., Stadler G., et al. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng 2007, 13:1173-1183.
37. Holfeld J., Tepeköylü C., Kozaryn R., Urbschat A., Zacharowski K., Grimm M., et al. Shockwave therapy differentially stimulates endothelial cells: implications on the control of inflammation via Toll-like receptor 3. Inflammation 2014, 37:65-70.
38. Moviglia G.A., Blasetti N., Zarate J.O., Pelayes D.E. In vitro differentiation of adult adipose mesenchymal stem cells into retinal progenitor cells. Ophthalm Res 2012, 48(Suppl 1):1-5.
39. Song K., Wang Z., Li W., Zhang C., Lim M., Liu T. In vitro culture, determination, and directed differentiation of adult adipose-derived stem cells towards cardiomyocyte-like cells induced by angiotensin II. Appl Biochem Biotechnol 2013, 170:459-470.
40. Sen A., Lea-Currie Y.R., Sujkowska D., Franklin D.M., Wilkison W.O., Halvorsen Y.D., et al. Adipogenic potential of human stromal cells from multiple donors is heterogeneous. JCell Biochem 2001, 81:312-319.
41. Zhu M., Kohan E., Bradley J., Hedrick M., Benhaim P., Zuk P. The effect of age on osteogenic, adipogenic and proliferative potential of female adipose-derived stem cells. JTissue Eng Regen Med 2009, 3:290-301.
42. Tsutsumi S., Shimazu A., Miyazaki K., Pan H., Koike C., Yoshida E., et al. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 2001, 288:413-419.
43. Lai W.-T., Krishnappa V., Phinney D.G. Fibroblast growth factor 2 (Fgf2) inhibits differentiation of mesenchymal stem cells by inducing Twist2 and Spry4, blocking extracellular regulated kinase activation, and altering Fgf receptor expression levels. Stem Cells 2011, 29:1102-1111.
44. Shahdadfar A., Frønsdal K., Haug T., Reinholt F.P., Brinchmann J.E. In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells 2005, 23:1357-1366.
45. Stolzing A., Coleman N., Scutt A. Glucose-induced replicative senescence in mesenchymal stem cells. Rejuvenation Res 2006, 9:31-35.
46. Schätti O., Grad S., Goldhahn J., Salzmann G., Li Z., Alini M., et al. Acombination of shear and dynamic compression leads to mechanically induced chondrogenesis of human mesenchymal stem cells. Eur Cell Mater 2011, 22:214-225.
47. Zorick T.S., Lemke G. Schwann cell differentiation. Curr Opin Cell Biol 1996, 8:870-876.
48. Cosgaya J.M., Chan J.R., Shooter E.M. The neurotrophin receptor p75NTR as a positive modulator of myelination. Science 2002, 298:1245-1248.
49. Jessen K.R., Mirsky R. The origin and development of glial cells in peripheral nerves. Nat Rev Neurosci 2005, 6:671-682.
50. Boland G.M., Perkins G., Hall D.J., Tuan R.S. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. JCell Biochem 2004, 93:1210-1230.
51. Fierro F., Illmer T., Jing D., Schleyer E., Ehninger G., Boxberger S., et al. Inhibition of platelet-derived growth factor receptorbeta by imatinib mesylate suppresses proliferation and alters differentiation of human mesenchymal stem cells in vitro. Cell Prolif 2007, 40:355-366.
52. Stenderup K., Justesen J., Eriksen E.F., Rattan S.I., Kassem M. Number and proliferative capacity of osteogenic stem cells are maintained during aging and in patients with osteoporosis. JBone Miner Res 2001, 16:1120-1129.
53. Chen C.-S. Phorbol ester induces elevated oxidative activity and alkalization in a subset of lysosomes. BMC Cell Biol 2002, 3:21.
54. Bergman R.J., Gazit D., Kahn A.J., Gruber H., McDougall S., Hahn T.J. Age-related changes in osteogenic stem cells in mice. JBone Miner Res 1996, 11:568-577.
55. McIntosh K., Zvonic S., Garrett S., Mitchell J.B., Floyd Z.E., Hammill L., et al. The immunogenicity of human adipose-derived cells: temporal changes in vitro. Stem Cells 2006, 24:1246-1253.
56. Frairia R., Berta L. Biological effects of extracorporeal shock waves on fibroblasts: a review. Muscles Ligaments Tendons J 2011, 1:138-147.
57. Huang C., Holfeld J., Schaden W., Orgill D., Ogawa R. Mechanotherapy: revisiting physical therapy and recruiting mechanobiology for a new era in medicine. Trends Mol Med 2013, 19:555-564.
58. Lauer U., Bürgelt E., Squire Z., Messmer K., Hofschneider P.H., Gregor M., et al. Shock wave permeabilization as a new gene transfer method. Gene Ther 1997, 4:710-715.